Announcements Trials
Browse Landscape

Phase

Phase 1 11Phase NA 9Phase 2 8Phase 1/2 3Phase 3 2Phase 4 1Phase 2/3 1

Status

Completed 106Unknown 34Recruiting 30Terminated 23Active not recruiting 8Not yet recruiting 7Withdrawn 4Suspended 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Neoplasms 1

Interventions

abarelix 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Suspended × Genitourinary × Clear all
NCT00103623 2006-09-19

The Plenaxis® Experience Study

PRAECIS Pharmaceuticals Inc.

Phase 4 Suspended
2,000 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡